How to Improve Influenza Vaccination Rates in the U.S. by Yoo, Byung-Kwang
*/530%6$5*0/
Annual epidemics of seasonal influenza occur during
autumn and winter in temperate regions and have
imposed substantial public health and economic burdens
[1,2]. At the global level, these epidemics cause about 3-
5 million severe cases of illness and about 0.25-0.5
million deaths each year [1]. Most influenza-associated
deaths in industrialized countries occur among people
aged 65 or older [1]. In the U.S. alone, influenza
epidemics were estimated to be associated with annual
averages of 36 000 deaths and 226 000 hospitalizations
[3,4]. There is limited literature on the disease burden of
influenza epidemics in developing countries [1].
Because annual vaccination is the most effective way
to prevent the disease or severe outcomes from the
illness [1], World Health Organization (WHO)
recommends it for nursing-home residents, elderly
individuals, people with certain chronic medical
conditions, and other groups including pregnant women,
health care workers, those with essential functions in
society, and children aged from six months to two years
[1]. In addition to these target populations recommended
by WHO, the U.S. Advisory Committee on Immuni-
zation Practices (ACIP) expanded its influenza
vaccination recommendation to include all adults aged
50 or older in 2000 [2], all children aged 6 months-18
years in 2008 [5], and all ages in 2010 [2].
Influenza vaccination coverage rates have been at
suboptimal levels in many countries. For instance, the
coverage rates among the elderly in 20 developed
nations in 2008 ranged from 21% to 78% (median 65%)
[6]. The coverage rates among the U.S. elderly have
been relatively high, partly because Medicare coverage
began as early as 1993. Namely, every Medicare
enrollee aged 65 or older can be vaccinated against
influenza with no out-of-pocket expenditure. However,
influenza vaccination levels among this population
appeared to reach a “plateau” of about 70% after the late
1990s [7]. Furthermore, the coverage rates for U.S. child
populations have remained at less than 50% [2].
In addition to such suboptimal coverage levels,
disparities in the coverage rates across subpopulations
within a country present another important public health
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Annual epidemics of seasonal influenza occur during autumn and winter in temperate regions and have imposed
substantial public health and economic burdens. At the global level, these epidemics cause about 3-5 million severe
cases of illness and about 0.25-0.5 million deaths each year. Although annual vaccination is the most effective way to
prevent the disease and its severe outcomes, influenza vaccination coverage rates have been at suboptimal levels in
many countries. For instance, the coverage rates among the elderly in 20 developed nations in 2008 ranged from 21% to
78% (median 65%). In the U.S., influenza vaccination levels among elderly population appeared to reach a “plateau” of
about 70% after the late 1990s, and levels among child populations have remained at less than 50%. In addition,
disparities in the coverage rates across subpopulations within a country present another important public health issue.
New approaches are needed for countries striving both to improve their overall coverage rates and to eliminate disparities.
This review article aims to describe a broad conceptual framework of vaccination, and to illustrate four potential
determinants of influenza vaccination based on empirical analyses of U.S. nationally representative populations. These
determinants include the ongoing influenza epidemic level, mass media reporting on influenza-related topics,
reimbursement rate for providers to administer influenza vaccination, and vaccine supply. It additionally proposes specific
policy implications, derived from these empirical analyses, to improve the influenza vaccination coverage rate and
associated disparities in the U.S., which could be generalizable to other countries.
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cc issue. The European and American literature documents
the presence of such disparities across subpopulations
defined by socio-economic factors such as income and
education levels [8]. Also, racial/ethnic disparities in the
influenza vaccination rate have been consistently
reported among the U.S. elderly [9,10] with Hispanic
and African-American populations having lower
influenza vaccination rates than white populations.
Considering the low coverage rates as well as the
presence of disparities in those rates, new approaches
will likely be needed to achieve the U.S. Healthy People
2020 goals [11]: (a) 80%-90% vaccination coverage
among the target populations and (b) eliminating
disparities in influenza vaccination rates. Such new
approaches would also be useful for other countries
striving both to improve their overall coverage rates and
to eliminate disparities.
This review article aims to describe potential new
approaches, mainly based on recently published
empirical studies conducted by the author and
colleagues. Specifically, this article first introduces a
broad conceptual framework of vaccination, and the
notion of avoidance response, a phenomenon in which
patients seek vaccination in response to an ongoing
influenza epidemic. It also illustrates four potential
determinants of influenza vaccination based on the
empirical analyses analyzing the U.S. nationally
representative populations. These determinants include
the ongoing influenza epidemic level, mass media
reporting on influenza-related topics, the reimbursement
rate for providers to administer influenza vaccination,
and vaccine supply. It additionally proposes specific
policy implications, derived from these empirical
analyses, to improve the influenza vaccination coverage
rate and associated disparities in the U.S., which could
be generalizable to other countries.
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Because a large number of factors involve vaccination,
a conceptual framework is useful to categorize these
factors. The conceptual framework of the studies by the
author and colleagues modified frameworks offered by
the Task Force on Community Preventive Services:
Focus on Vaccine-Preventable Disease, and others
[12,13]. The four focal domains of vaccination involve
patients, healthcare providers, system and epidemic
factors (Figure 1). The final domain of epidemic factors
was added by the author. Epidemic factors include,
ongoing and past epidemics, measured by the rates of
transmission, morbidity, and mortality when infected by
influenza. Perceived risk of influenza infection, among
patient factors, will be affected by the information about
ongoing influenza epidemic and the mass media reports
on influenza infection. Examples of provider factors and
system factors are reimbursement rate and vaccine
supply, respectively.
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I. Epidemic Factor: Ongoing Epidemic
Leading to “Avoidance Response”
Influenza vaccine demand, particularly late-season
demand, is difficult to predict for two reasons. First,
influenza vaccine manufacturers take vaccine orders as
early as January of the prior season because the vaccine
production process takes eight or nine months. Secondly,
demand may rise when an influenza epidemic is
perceived to be severe or to start early, while demand
may decline when influenza epidemic activity is
perceived to be mild. Because influenza activity peaks
after January in most seasons, epidemic activity usually
influences late-season demand [18].
Information on “avoidance response” could improve
efficiency in the distribution of influenza vaccine,
particularly after the onset of an epidemic. This is because
if “short-term” avoidance response exists, weekly
influenza epidemic change is positively associated with
overall annual influenza vaccine receipt as well as daily
vaccine receipt. Empirical evidence of this association
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Figure 1. Conceptual model of vaccination.
Factors in bold are detailed with key references [14-17] in the main
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might also help predict short-term, late-season vaccine
demand, enabling better seasonal influenza vaccine
distribution and redistribution, thus improving the overall
vaccine coverage rate. Moreover, estimation of short-term
avoidance response (responsiveness) to epidemic activity
might be useful in pandemic influenza planning because
of the possible insufficient vaccine supply compared to the
demand for pandemic vaccine [19].
To the best of our knowledge, previous studies have
quantitatively measured only long-term avoidance-
response with a one-year lag, e.g., past season’s
epidemic level, not ongoing epidemic level. Namely,
these past studies reported that a past season’s higher
epidemic level was associated with the subsequent
season’s higher vaccine coverage rates [20-22].
The study by the author and colleagues analyzed five
influenza seasons since 2000 [14]. These five seasons
varied in terms of the timing and severity of the
epidemics and the vaccine supply shortage/delay. This
study conducted cross-sectional survival analyses from
the 2000-2001 to 2004-2005 influenza seasons among
the U.S. nationally representative community-dwelling
elderly enrolled in the Medicare Current Beneficiary
Survey (MCBS) (weighted N=7.7-9.7 million per
season), shown in Table 1 (row 1). The dependent
variable was daily vaccine receipt, measured from
September 1st in each year. Independent variables
included the biweekly epidemic changes, the vaccine
supply at nine census-region levels, and fifteen
individual factors.
As hypothesized, biweekly epidemic change was
positively associated with overall annual vaccination
(e.g., 2.7% increase in 2003-2004 season) as well as
earlier vaccination timing (p<0.01), which was robust in
all five seasons. The magnitude of this association was
also robust in all five seasons [14]. Namely,
unvaccinated individuals were 5-29% more likely to
receive vaccination subsequent to a 100% biweekly
epidemic increase.
Therefore, this study concluded that the measurement
of short-term avoidance response (i.e., epidemic-
responsiveness in demand for influenza vaccination)
may improve (a) seasonal influenza vaccine distribution
and the annual seasonal influenza vaccination rate and
(b) might assist pandemic influenza preparedness
planning [14].
II. Patient Factor: Mass Media Coverage on
Influenza-Related Topic
Although the previous section described ongoing
epidemic level as a potential strong determinant of
influenza vaccination, the peak of vaccine receipts (and
vaccine campaigns) was usually prior to the end of
November, well before the onset of seasonal influenza
epidemic [14,18]. Additionally, some individuals tend to
lose an incentive for the influenza vaccine receipt after a
certain time in a season. For instance, a large number of
vaccines delivered to clinics after November were
unused during the 2000-2001 season with a serious
vaccine supply shortage [23], although an influenza
epidemic cousld start in January and end in April as
observed in 2002 [24]. Therefore, to improve vaccine
coverage rates during a typical influenza vaccine
campaign period, another potential determinant (mass
media reporting) is discussed in this section.
The literature suggests that mass media considerably
affects a person’s knowledge of health and her/his use of
health services [25,26]. For example, a celebrity
campaign on colon cancer screening on the U.S. NBC’s
Today’s Show was reported to increase the colonoscopy
rate by 38% during the nine months following the airing
of the show [27]. Although influenza was ranked 4th
among all health news stories followed by the American
public during 1996-2002 [26], only a few studies have
measured the effect of mass media on influenza
vaccination [16,28-31].
The study by the author and colleagues [16] aimed to
fill the gap in the past studies in four areas. First, these
past studies analyzed at best a state-level population [28-
31], not a nationally representative population. Second,
these studies lacked a quantitative measure of media
exposure, except one by Ma et al. [31]. Third, none of
these studies controlled for other potential confounders,
e.g., vaccine supply shortage. Finally, none of them
explicitly measured the mass media effect on the
vaccination timing (closer in time to media exposure) as
well as annual vaccination rate.
The purpose of the study by the author and colleagues
[16] was to examine the association between mass media
coverage on flu-related topics and influenza vaccination
- concerning both vaccination timing and annual
vaccination rates - among a nationally representative
Medicare elderly population. Focusing on short time
frames enabled this study to distinguish, at the individual
level, between media exposure prior to vaccination and
unrelated media exposure after vaccination. It also
allowed this study to adjust for vaccine shortages at short
intervals.
The study by the author and colleagues focused on the
U.S. nationally representative community-dwelling
elderly, enrolled in 1999, 2000 and 2001 MCBS [16].This study performed cross-sectional survival analyses
during each of three influenza vaccination seasons
between September 1999 and December 2001, as in
Table 1 (row 2). The dependant variable was daily
vaccine receipt measured from September 1 in each
season. Daily media coverage was measured by
counting the number of television program transcripts
(in 4 major networks - ABC, CBS, FOX and NBC) and
national newspaper/ wire service articles (USA Today
and  Associated Press), including keywords of
influenza/flu and vaccine shortage/delay. All models’
covariates included three types of media, CDC press
release, vaccine supply, three regional factors, and
seventeen individual factors.
Influenza-related reports in all three mass media
sources had a positive association with earlier
vaccination timing as well as annual vaccination rate
[16]. Among these three mass media sources, television
networkssreports had the most consistent positive
effects in all models, e.g., changing the mean vaccination
timing earlier by 1.8-4.1 days (p<0.001) or raising the
annual vaccination rate by 2.3-7.9% (p<0.001).
Particularly, these associations tended to be stronger
when reported in a headline rather than in text only and
if including additional keywords, e.g., vaccine
shortage/delay.
This study’s empirical results might help justify and
strengthen various forms of vaccination campaigns by
CDC or other public institutions [16]. Specific policy
implications for campaigns using mass media
(newspapers or television) are exemplified by: (i) using a
headline, as well as text, which includes specific key
words like shortage/delay in addition to influenza alone;
(ii) performing repeated media campaign use rather than
one-time use, because of the suggested short-term media
effect and the cumulative effects during a period; and
(iii) securing adequate vaccine supply prior to a media
campaign release on supply delay/shortage due to
individuals’ quick response to such release [16].
III. Provider Factor: Reimbursement Rate
for Physician Providers
Physician recommendations have been reported to be
among the strongest predictors of influenza vaccine
receipt among the U.S. population [2]. Therefore,
exploring an appropriate physician reimbursement
policy is important to increase the vaccination coverage
rates.
It should be noted that a U.S. reimbursement policy
for vaccination consists of two components, i.e.,
reimbursement for vaccine purchase and vaccine
administration. The former component’s financial risk
for providers was reduced substantially after the launch
of the U.S. federal program Vaccine for Children (VFC)
which delivers free vaccines for eligible providers [32].
However, the latter component’s financial risk for
providers still remains if the actual provider costs of
administering vaccinations are higher than the
reimbursement rate.
Three phenomena on influenza vaccination motivated
the study by the author and colleagues [15]. First,
compared to provider costs for administering child
influenza vaccination ($20 per dose at the national-level
in 2006 U.S. dollar) [33], inadequate reimbursement
rates were reported by recent studies [33-35]. For
instance, the provider cost of $20 was much higher than
the average state Medicaid reimbursement rate of $8
(ranging from $2 to $18) in 2005 [15]. Second, wide
disparities have been noted in influenza vaccination rates
between poor and higher-income children and across
states [36-38]. For instance, the influenza vaccine
coverage rates among the children aged 6-23 months at
the state level ranged from 1.6% (in Mississippi State) to
40.6% (in Rhode Island State) in 2005 [37]. Third,
although some literature exists to suggest that higher
reimbursement may improve vaccination levels [39,40],
most of the evidence is either indirect or pertains to adult
vaccinations.
Based on these phenomena, two hypotheses were
proposed: (1) In the individual-level multivariate
analysis, higher Medicaid administration reimbursement
rates would be positively associated with a greater
likelihood of vaccine receipt among Medicaid eligible
poor children, and (2) In the state-level analysis,
Medicaid reimbursement rates would be positively
associated with statewide influenza vaccination rates
among Medicaid eligible poor children.
Specifically, this study assessed influenza vaccination
rates among nationally representative children aged 6-23
months during the 2005-2006, 2006-2007 and 2007-
2008 influenza seasons, using the U.S. National
Immunization Surveys (NIS) (weighted N=3.3 -4.0
million per season). This study categorized children into
three income levels (poor, near-poor, non-poor), where
poor children represented those who were Medicaid
eligible (in all states based on federal poverty level
below 100%). This study implemented cross-sectional
multivariable logistic regression analyses where full
influenza vaccination was the dependent variable. The
key covariates were the state Medicaid reimbursement
rate (a continuous variable, ranging from $2 to $17.86
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per vaccination) and its interaction terms with income
levels. Other covariates included twelve individual
factors and four state-level factors.
Altogether, 21.0%, 21.3%, and 28.9% of all U.S.
children and 11.7%, 11.6%, and 18.8% of poor children
were fully vaccinated during the 2005-2006, 2006-2007
and 2007-2008 influenza seasons, respectively. As
shown in Table 1 (row 3), this study’s multivariable
analyses found a positive and significant (all p<0.05)
association between state-level Medicaid reimbursement
and influenza vaccination rates among poor children,
which was robust in all three seasons. The magnitude of
this association is substantial. If a Medicaid program
increased the reimbursement rate by ten dollars - the
difference between the U.S. average ($8 per influenza
vaccination) and the highest state reimbursement ($18) -
the increase was expected to raise the full vaccination
rate among poor children by 6.0, 9.2 and 6.4 percentage
points at the state-level during the 2005-2006, 2006-
2007 and 2007-2008 influenza seasons, respectively.
A potential policy implication, based on these
empirical results, is to increase Medicaid reimbursement
rates that could improve vaccine coverage among
Medicaid eligible poor children. The VFC program,
providing free vaccines for Medicaid eligible children,
was reported to be associated with a reduction in
physician referrals to health departments and also with
rising overall vaccination rates [41,42]. However, the
VFC program alone does not seem adequate for
providers who remain at financial risk due to inadequate
reimbursement to cover vaccine administration costs.
IV. System Factor: Vaccine Supply Effect on
Racial/Ethnic Disparity
There were five seasons of influenza vaccine supply
problem (delay, shortage or both) in the U.S. since 2000
(CDC. Cumulative monthly U.S. influenza vaccine
distribution, 1999-2006, Unpublished data, 2006) [43].
During these five seasons, influenza vaccine coverage
rates in the U.S. tended to be lower [44-46].
Approximately 15% of the U.S. Medicare beneficiaries
experienced difficulties in receiving an influenza
vaccination, due to the limited influenza vaccine
availability [45], and many high-priority groups did not
seek vaccination because of their perception of an
influenza vaccine shortage during the 2004-2005 season
[47]. Despite recent progress in bolstering the production
capacity of the U.S. influenza vaccine market [48],
inadequacies in supply remain due to the uncertainty
regarding regulation compliance by manufacturers [49].
A number of studies tested a hypothesis that disparities
in influenza vaccination will be exacerbated when
vaccine supply declines or is delayed [17,50]. This is
because vulnerable populations, such as underserved
racial and ethnic populations, may face relatively greater
barriers to accessing limited vaccines during such
seasons with vaccine supply problem. Link et al.
reported no significant change in disparities by race or
ethnicity among the adults aged 65 or older during the
2004-2005 season compared to prior seasons based on
their analysis of the U.S. nationally representative
Behavioral Risk Factor Surveillance System (BRFSS)
dataset [50].
A methodological limitation of the study by Link et al.
motivated the study by the author and colleagues. Their
limitation was due to the design of BRFSS datasets,
collecting a different set of subjects every year and hence
only enabling a cross-sectional analysis. However, a
cross-sectional analysis is unable to adequately adjust for
potential time-varying confounders (e.g., vaccine supply,
health status and any unobservable factors) that may
disproportionally affect persons in each racial/ethnic
group. A cohort analysis can address this issue more
appropriately. This is because potentially confounding
variables within the same subjects are likely to change
relatively little between two consecutive seasons.
Therefore, the study by the author and colleagues [17]
implemented a cohort analysis of subjects followed over
two consecutive seasons with different levels of vaccine
supply. Specifically, this study conducted cross-sectional
multivariable logistic regression analyses to examine
whether racial/ethnic disparities in vaccination rates
changed across two consecutive seasons: from (period 1)
2000-2001 and 2001-2002 seasons through (period 4)
2003-2004 and 2004-2005 seasons. The dependent
variable was self-reported receipt of influenza vaccine
across consecutive years among the U.S. nationally
representative community dwelling non-Hispanic
African-American (AA), non-Hispanic White (W),
English-speaking Hispanic (EH) and Spanish-speaking
Hispanic (SH) elderly, who were enrolled in the MCBS
(weighted N = 8.23-8.99 million for periods 1-4).
Independent variables included three racial/ethnic
categories and sixteen individual level factors.
The main findings are presented in Table 1 (bottom
row). When vaccine supply increased nationally during
periods 1 and 2, adjusted racial/ethnic disparities in the
influenza vaccination coverage rate decreased by 1.8-
7.4% (W-AA disparity), 4.5-6.6% (W-EH disparity) and
6.6-11% (W-SH disparity) (all p<0.001). On the other
hand, when vaccine supply declined during period 4, #ZVOH,XBOH:PP
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adjusted disparities in vaccination coverage rates
increased by 2.3% (W-AA disparity) and 6.1% (W-EH
disparity).
Therefore, this paper concluded that improved vaccine
supply was generally associated with narrowed or
improved racial/ethnic disparities in influenza
vaccination rates and that reduced supply was associated
with widened or worsened disparities. In order to avoid
future widening of racial/ethnic disparities in influenza
vaccination rates, policy implications include
stabilization of the vaccine supply and preferential
delivery of vaccines to safety-net providers serving
vulnerable population such as AA and Hispanic
populations during a vaccine supply shortage.
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In order to improve influenza vaccination coverage
rates regarding both the overall rates and the disparities
across subpopulations, multi-dimension policies
(suggested by our conceptual model in Figure 1) seem to
be needed. In addition, as adopted in the studies
introduced in this paper, the analysis of nationally
representative populations and the utilization of rigorous
methodologies are needed to provide policy implications
which are generalizable at a national level and probably
in other countries.
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